The novel association of a cytokine cluster in the IL5-IL13 region for the EoE trait is particularly interesting since anti-IL5 monoclonal antibodies have been recommended as a novel therapeutic agent for EoE and other eosinophilia–related traits (Corren, 2012). The gene discussed is IL5; the disease is eosinophilic esophagitis.